Primum Health Raises Seed Round Led by FCA Venture Partners and North Coast Ventures
Funding will fuel rapid expansion of the Columbus-based oncology platform, which connects community oncologists with subspecialty experts and real-world insights...
Day: September 25, 2025
cbdMD Announces Inferno Freeze: Our Most Powerful Topical
Charlotte, North Carolina--(Newsfile Corp. - September 25, 2025) - cbdMD, Inc. (NYSE American: YCBD), one of the nation's leading and...
Medical Care Technologies Inc. Expands AI Platform to Detect Glaucoma and Cataracts
MESA, ARIZONA / ACCESS Newswire / September 25, 2025 / Medical Care Technologies Inc. (OTC PINK:MDCE) announced that its AI...
Alliance for Pharmacy Compounding Joins Pharmacy Podcast Network with New “Essential” Podcast
With podcasting reaching over 210M people in the United States today, building reliable content for Providers and business professionals in...
Jaguar Health Receives Notice of $250,000 FDA Grant to Fund Confirmatory Trial to Support FDA Approval of Canalevia for Treatment of Chemotherapy-Induced Diarrhea (CID) in Dogs
Company strategy: In discussions with multiple potential animal health company partners to expand the indication and commercialize Canalevia for treatment...
Smile Digital Health Pledges Foundational Technology Support to Power the CMS Health Tech Ecosystem
TORONTO, ON / ACCESS Newswire / September 25, 2025 / Smile Digital Health, a provider of enterprise-grade, open-framework health data...
Dr. Ran Rubinstein Explains His Sculptra Approach to Natural Volume Restoration
By combining experience in facial anatomy with advanced Sculptra injection strategies, Dr. Ran Rubinstein helps patients achieve gradual, long-lasting improvements...
Safety Shot Partners with Monarq Asset Management to Actively Manage BONK Holdings Treasury
Institutional-Grade Asset Manager Retained to Monetize BONK Treasury, Generate Yield, and Preserve Shareholder Value SCOTTSDALE, AZ, Sept. 25, 2025 (GLOBE...
Philips joins Optum Healthcare’s network as a preferred provider in the USA
Philips Joins Optum Healthcare’s Network as Preferred Provider September 25, 2025 Philips’ ambulatory and diagnostic solutions and services are now...
HealthEquity Strengthens Executive Leadership Team with Strategic Appointments to Drive Growth and Innovation
New CMO and Sales Executive Join from Mastercard and EverQuote to Capitalize on Historic HSA Market ExpansionDRAPER, Utah, Sept. 25,...
Femasys Accelerates European Growth for FemBloc® with Kebomed Partnership
-- Femasys leverages Kebomed’s pan-European distribution strength to drive adoption of FemBloc permanent birth control in France and Benelux, unlocking...
Silexion Therapeutics Regains Compliance with Nasdaq Listing Requirements
Company Successfully Meets Both Minimum Bid Price and Shareholders' Equity Requirements, Securing Continued Listing on the Nasdaq Capital MarketGRAND CAYMAN,...
AIM ImmunoTech Secures Patent in Japan Through 2039 for Novel Cancer Therapy Combining Ampligen® (Rintatolimod) with Checkpoint Inhibitors
Patent supports AIM’s strategy to expand international market protection, providing opportunities for licensing, collaborations, and long-term revenue growth Japan is...
Moleculin Announces Notice of Allowance for Canadian Patent Covering Annamycin
HOUSTON, Sept. 25, 2025 (GLOBE NEWSWIRE) -- Moleculin Biotech, Inc., (Nasdaq: MBRX) (“Moleculin” or the “Company”), a late-stage pharmaceutical company...
LB Pharmaceuticals Strengthens Board of Directors with Appointments of William Kane and Rekha Hemrajani
NEW YORK, Sept. 25, 2025 (GLOBE NEWSWIRE) -- LB Pharmaceuticals Inc (“LB Pharmaceuticals” or the “Company”) (Nasdaq: LBRX) today announced...
CytoDyn to Present on Leronlimab Induction of PD-L1 and Immune Checkpoint Inhibitor Responses in Metastatic Triple-Negative Breast Cancer at the AACR Special Conference: Mechanisms of Cancer Immunity and Cancer-related Autoimmunity
Company to deliver oral and poster presentations for data on leronlimab’s action on PD-L1 expression and patient survival in triple-negative...
RenovoRx’s PanTheR Post-Marketing Registry Study Progresses with First Clinical Procedure and Addition of Two Participating Clinical Sites
First Registry-Eligible Patient Procedure Commenced at the University of Vermont Cancer Center Baptist Health Miami Cancer Institute and University of...
Nexalin Technology Announces Issuance of U.S. Patent Covering HALO™ Clarity Device Featuring DIFS™ Technology
HOUSTON, TX, Sept. 25, 2025 (GLOBE NEWSWIRE) -- Nexalin Technology, Inc. (Nasdaq: NXL; NXLIW) (the “Company” or “Nexalin”), the leader...
Tevogen Marks Major Milestone in Its AI Initiative to Enhance Efficacy of T Cell–Based Therapies with 100x PredicTcell™ Beta Data Expansion
Beta version of PredicTcell™ expands training dataset to ~1.4 million and total dataset to over 6.7 billion records.Potential future T...
Commure Partners with Bethany Children’s Health Center to Help Reduce Clinician Documentation Burden and Enhance Productivity
Robust healthcare platform to streamline workflows across inpatient and outpatient settingsMOUNTAIN VIEW, Calif., Sept. 25, 2025 (GLOBE NEWSWIRE) -- Commure,...